Kazia Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZIA and other ETFs, options, and stocks.About KZIA
Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer.
CEOJohn E. Friend
CEOJohn E. Friend
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1994
Founded1994
Employees—
Employees—
KZIA Key Statistics
Market cap10.47M
Market cap10.47M
Price-Earnings ratio-0.51
Price-Earnings ratio-0.51
Dividend yield—
Dividend yield—
Average volume25.95K
Average volume25.95K
High today$7.11
High today$7.11
Low today$6.26
Low today$6.26
Open price$7.11
Open price$7.11
Volume69.71K
Volume69.71K
52 Week high$30.05
52 Week high$30.05
52 Week low$2.86
52 Week low$2.86
Stock Snapshot
Kazia Therapeutics(KZIA) stock is priced at $6.26, giving the company a market capitalization of 10.47M. It carries a P/E multiple of -0.51.
On 2025-11-15, Kazia Therapeutics(KZIA) stock traded between a low of $6.26 and a high of $7.11. Shares are currently priced at $6.26, which is 0.0% above the low and -12.0% below the high.
Kazia Therapeutics(KZIA) shares are trading with a volume of 69.71K, against a daily average of 25.95K.
In the last year, Kazia Therapeutics(KZIA) shares hit a 52-week high of $30.05 and a 52-week low of $2.86.
In the last year, Kazia Therapeutics(KZIA) shares hit a 52-week high of $30.05 and a 52-week low of $2.86.